Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 80
Filter
1.
Mastology (Online) ; 332023. ilus, tab
Article in English | LILACS | ID: biblio-1433826

ABSTRACT

:Breast cancer is the object of thousands of studies worldwide. Nevertheless, few tools are available to corroborate prediction of response to neoadjuvant chemotherapy. Artificial intelligence is being researched for its potential utility in several fields of knowledge, including oncology. The development of a standardized Artificial intelligence-based predictive model for patients with breast cancer may help make clinical management more personalized and effective. We aimed to apply Artificial intelligence models to predict the response to neoadjuvant chemotherapy based solely on clinical and pathological data. Methods: Medical records of 130 patients treated with neoadjuvant chemotherapy were reviewed and divided into two groups: 90 samples to train the network and 40 samples to perform prospective testingand validate the results obtained by the Artificial intelligence method. Results: Using clinicopathologic data alone, the artificial neural network was able to correctly predict pathologic complete response in 83.3% of the cases. It also correctly predicted 95.6% of locoregional recurrence, as well as correctly determined whether patients were alive or dead at a given time point in 90% of the time. To date, no published research has used clinicopathologic data to predict the response to neoadjuvant chemotherapy in patients with breast cancer, thus highlighting the importance of the present study. Conclusions: Artificial neural network may become an interesting tool for predicting response to neoadjuvant chemotherapy, locoregional recurrence, systemic disease progression, and survival in patients with breast cancer (AU)


Subject(s)
Humans , Female , Middle Aged , Breast Neoplasms/drug therapy , Artificial Intelligence , Neoadjuvant Therapy , Antineoplastic Agents/therapeutic use , Progesterone/metabolism , Retrospective Studies , Neural Networks, Computer , Receptor, ErbB-2/metabolism , Ki-67 Antigen/metabolism , Estrogens/metabolism , Neoplasm Recurrence, Local
2.
Journal of Southern Medical University ; (12): 432-437, 2022.
Article in Chinese | WPRIM | ID: wpr-936334

ABSTRACT

OBJECTIVE@#To explore the mechanism by which estradiol modulates the immunophenotype of macrophages through the endoplasmic reticulum stress pathway.@*METHODS@#Peritoneal macrophages isolated from C57 mice were cultured in the presence of 60 ng/mL interferon-γ (IFN-γ) followed by treatment with estradiol (1.0 nmol/L) alone, estradiol with estrogen receptor antagonist (Acolbifene, 4 nmol/L), estradiol with IRE1α inhibitor (4 μ 8 C), or estradiol with IRE1α agonist. After the treatments, the expression levels of MHC-Ⅱ, iNOS and endoplasmic reticulum stress marker proteins IRE1α, eIF2α and ATF6 in the macrophages were detected with Western blotting, and the mRNA levels of TGF-β, IL-6, IL-10 and TNF-α were detected with RT-PCR.@*RESULTS@#Estrogen treatment of the macrophages significantly decreased the expressions of M1-related proteins MHC-Ⅱ (P=0.021) and iNOS (P < 0.001) and the mRNA expressions of TNF-α (P=0.003) and IL-6 (P=0.004), increased the mRNA expression of TGF-β (P=0.002) and IL-10 (P=0.008), and up-regulated the protein expressions of IRE1α (P < 0.001) and its downstream transcription factor XBP-1 (P < 0.001). Addition of the estrogen inhibitor obviously blocked the effect of estrogen. Compared with estrogen treatment alone, combined treatment of the macrophages with estrogen and the IRE1α inhibitor 4 μ 8 C significantly up-regulated the protein expressions of MHC-Ⅱ (P=0.002) and iNOS (P=0.003) and the mRNA expressions of TNF-α (P=0.003) and IL-6 (P=0.024), and obviously down-regulated the mRNA expression of TGF-β (P < 0.001) and IL-10 (P < 0.001); these changes were not observed in cells treated with estrogen and the IRE1α agonist.@*CONCLUSION@#Estrogen can inhibit the differentiation of murine macrophages into a pro-inflammatory phenotype by up-regulating the IRE1α-XBP-1 signaling axis, thereby producing an inhibitory effect on inflammatory response.


Subject(s)
Animals , Mice , Cell Differentiation/drug effects , Endoribonucleases/metabolism , Estradiol/pharmacology , Estrogens/metabolism , Interleukin-10 , Interleukin-6/metabolism , Macrophages, Peritoneal/metabolism , Phenotype , Protein Serine-Threonine Kinases/metabolism , RNA, Messenger/metabolism , Signal Transduction/drug effects , Transforming Growth Factor beta/metabolism , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation/drug effects , X-Box Binding Protein 1/metabolism
4.
Rev. Assoc. Med. Bras. (1992) ; 62(1): 72-77, Jan.-Feb. 2016. graf
Article in English | LILACS | ID: lil-777437

ABSTRACT

SUMMARY Even though the physiological role of estrogen in the female reproductive cycle and endometrial proliferative phase is well established, the signaling pathways by which estrogen exerts its action in the endometrial tissue are still little known. In this regard, advancements in cell culture techniques and maintenance of endometrial cells in cultures enabled the discovery of new signaling mechanisms activated by estrogen in the normal endometrium and in endometriosis. This review aims to present the recent findings in the genomic and non-genomic estrogen signaling pathways in the proliferative human endometrium specifically associated with the pathogenesis and development of endometriosis.


RESUMO Embora esteja bem estabelecido o papel fisiológico do estrogênio no ciclo reprodutivo feminino e na fase proliferativa do endométrio, as vias de sinalização por meio das quais a ação do estrogênio é exercida no tecido endometrial são ainda pouco conhecidas. Nesse sentido, o avanço nas técnicas de cultura celular e a manutenção de células endometriais em cultivo possibilitaram a descoberta de novos mecanismos sinalizadores ativados pelo estrogênio no endométrio normal e na endometriose. Esta revisão tem o objetivo de apresentar as descobertas recentes envolvendo as vias de sinalização genômica e não genômica do estrogênio no endométrio proliferativo humano, especificamente associadas à patogênese e ao desenvolvimento da endometriose.


Subject(s)
Humans , Female , Receptors, Estrogen/metabolism , Endometriosis/physiopathology , Endometriosis/metabolism , Endometrium/physiopathology , Endometrium/metabolism , Estrogens/metabolism , Signal Transduction , Receptors, Estrogen/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Endometriosis/genetics , Estrogens/genetics
5.
Braz. j. med. biol. res ; 48(2): 146-153, 02/2015. tab, graf
Article in English | LILACS | ID: lil-735854

ABSTRACT

Although 17β-estradiol (E2) deficiency has been linked to the development of osteoarthritis (OA) in middle-aged women, there are few studies relating other estrogens and estrogen metabolites (EMs) to this condition. We developed a high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (HPLC-ESI-MS/MS) method to measure the levels of six EMs (i.e., estrone, E2, estriol, 2-hydroxyestrone, 2-hydroxyestradiol, and 16a-hydroxyestrone) in healthy pre- and postmenopausal women and women with OA. This method had a precision ranging from 1.1 to 3.1% and a detection limit ranging from 10 to 15 pg. Compared to healthy women, serum-free E2 was lower in the luteal and postmenopausal phases in women with OA, and total serum E2 was lower in postmenopausal women with OA. Moreover, compared to healthy women, total serum 2-hydroxyestradiol was higher in postmenopausal women with OA and total serum 2-hydroxyestrone was lower in both the luteal and follicular phases in women with OA. In conclusion, our HPLC-ESI-MS/MS method allowed the measurement of multiple biochemical targets in a single assay, and, given its increased cost-effectiveness, simplicity, and speed relative to previous methods, this method is suitable for clinical studies.


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Chromatography, High Pressure Liquid/methods , Estrogens/blood , Osteoarthritis/blood , Postmenopause/blood , Premenopause/blood , Spectrometry, Mass, Electrospray Ionization/methods , Estradiol/analogs & derivatives , Estradiol/blood , Estriol/blood , Estrogens/metabolism , Estrone/blood , Follicular Phase/blood , Hydroxyestrones/blood , Limit of Detection , Luteal Phase/blood , Osteoarthritis/metabolism , Postmenopause/metabolism , Premenopause/metabolism , Statistics, Nonparametric
6.
The Korean Journal of Gastroenterology ; : 201-208, 2014.
Article in Korean | WPRIM | ID: wpr-192823

ABSTRACT

Gender difference in the incidence of colorectal cancer is well known and has been supported by various epidemiologic studies. In Korea, women have lower incidence of colorectal cancer and adenoma, and the incidence in men has recently increased. Hormone replacement therapy in menopausal women is preventive of colorectal cancer but can cause cardiovascular diseases and breast cancer. Estrogen exerts diverse effects through estrogen receptors, ERalpha and ERbeta. ERbeta is associated with anti-proliferation and apoptosis. The ratio of ERalpha/ERbeta is important in the protection and tumorigenesis of colorectal cancer. Therefore ERbeta modulation has been investigated for preventing or treating colorectal cancer and avoiding adverse effects of estrogen at the same time. In addition, the gender-difference in the incidence of colorectal cancer should be taken into account when making guidelines on colorectal surveillance for Korean population.


Subject(s)
Humans , Adenoma/diagnosis , Colorectal Neoplasms/diagnosis , Estradiol Dehydrogenases/metabolism , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/metabolism , Estrogens/metabolism , Sex Factors
7.
Clinics ; 68(12): 1537-1542, dez. 2013. graf
Article in English | LILACS | ID: lil-697707

ABSTRACT

OBJECTIVES: Estrogen has been shown to play an important protective role in non-reproductive systems, such as the cardiovascular system. Our aim was to observe gender differences in vivo with regard to the increase in macromolecular permeability and leukocyte-endothelium interaction induced by ischemia/reperfusion as well as in microvascular reactivity to vasoactive substances using the hamster cheek pouch preparation. METHODS: Thirty-six male and 36 female hamsters, 21 weeks old, were selected for this study, and their cheek pouches were prepared for intravital microscopy. An increase in the macromolecular permeability of post-capillary venules was quantified as a leakage of intravenously injected fluorescein-labeled dextran, and the leukocyte-endothelium interaction was measured as the number of fluorescent rolling leukocytes or leukocytes adherent to the venular wall, labeled with rhodamin G, during reperfusion after 30 min of local ischemia. For microvascular reactivity, the mean internal diameter of arterioles was evaluated after the topical application of different concentrations of two vasoconstrictors, phenylephrine (α1-agonist) and endothelin-1, and two vasodilators, acetylcholine (endothelial-dependent) and sodium nitroprusside (endothelial-independent). RESULTS: The increase in macromolecular permeability induced by ischemia/reperfusion was significantly lower in females compared with males [19 (17-22) leaks/cm2 vs. 124 (123-128) leaks/cm2, respectively, p<0.001), but the number of rolling or adherent leukocytes was not different between the groups. Phenylephrine-induced arteriolar constriction was significantly lower in females compared with males [77 (73-102)% vs. 64 (55-69)%, p<0.04], but there were no detectable differences in endothelin-1-dependent vasoreactivity. Additionally, arteriolar vasodilatation elicited by acetylcholine or sodium nitroprusside did not differ between the groups. CONCLUSION: The ...


Subject(s)
Animals , Cricetinae , Female , Male , Cardiovascular System/metabolism , Estrogens/metabolism , Microcirculation/physiology , Acetylcholine/pharmacology , Capillary Permeability , Cell Adhesion/physiology , Cheek/blood supply , Endothelium, Vascular/physiology , Leukocytes/physiology , Nitroprusside/pharmacology , Phenylephrine/pharmacology , Reperfusion Injury/metabolism , Sex Factors , Time Factors
8.
An. bras. dermatol ; 88(4): 578-584, ago. 2013. tab, graf
Article in English | LILACS | ID: lil-686524

ABSTRACT

In this article, three cases of hereditary angioedema (HAE) type III (estrogen-dependent or with normal C1 inhibitor) are reported. The HAE was initially described in women of the same family in association with high-leveled estrogenic conditions such as the use of oral contraceptives and pregnancy. There is no change in the C1 inhibitor as happens in other types of hereditary angioedema, and mutations are observed in the encoding gene of the XII factor of coagulation in several patients. The current diagnosis is mainly clinical and treatment consists in the suspension of the triggering factors and control of acute symptoms. A brief review of physiopathology, clinical features, genetic alterations and treatment are also presented.


Neste artigo são relatados três casos de angioedema hereditário do tipo III (estrógeno-dependente ou com inibidor de C1 normal), que foi inicialmente descrito em mulheres da mesma família, em associação com condições de alto nível estrogênico, como uso de anticoncepcionais orais e gravidez. Não há alteração do inibidor de C1, como acontece nos outros tipos de angioedema hereditário, e são observadas mutações no gene codificador do fator XII da coagulação em várias pacientes. O diagnóstico atualmente é eminentemente clínico e o tratamento consiste na suspensão dos fatores desencadeantes e controle dos sintomas agudos. Também é apresentada breve revisão da fisiopatogenia, quadro clínico, alterações genéticas e tratamento.


Subject(s)
Adult , Female , Humans , Hereditary Angioedema Type III/genetics , Complement C1 Inhibitor Protein/metabolism , Estrogens/metabolism , Hereditary Angioedema Type III/diagnosis , Hereditary Angioedema Type III/therapy , Lip , Mutation , Treatment Outcome
9.
Acta cir. bras ; 28(6): 412-418, June 2013. ilus, tab
Article in English | LILACS | ID: lil-675574

ABSTRACT

PURPOSE: To evaluate the bone repair process in ovariohysterectomized rabbit submitted to an ovarian transplant to stomach that may supplying some quantity of estrogen occurs to improve bone healing. METHODS: In 20 female rabbits three holes of 1, 2 and 3mm diameter in tibial shaft were made and after that all animals received OHE through a ventral incision and they were randomly divided into two groups of ten rabbits each. In group one, animals received one of their self-ovaries that transplanted on serosal layer of stomach and group two did not receive treatment. Animals were kept during bone healing for a period of 45 days and radiological, biochemical, biomechanical and histopathological evaluation. RESULTS: The tibial defects in group one healed completely after 45 days and had more callous than second group. There is significant difference between two groups after operation in 21, 28 and 35 days about estrogen, progesterone and phosphatase Alkaline. The maximum forces in group one, were significantly higher than that for the group two. CONCLUSION:Ovarian transplantation prevents the effects of ovariohysterectomized on bone healing of rabbit tibia, suggesting that unilateral transplanted ovaries can substitute for the action of ovaries on the skeleton in ovariohysterectomized animals.


Subject(s)
Animals , Female , Rabbits , Bone Regeneration/physiology , Hysterectomy , Ovariectomy , Ovary/transplantation , Stomach/surgery , Tibia/injuries , Wound Healing/physiology , Alkaline Phosphatase/metabolism , Estrogens/metabolism , Progesterone/metabolism , Time Factors
10.
Experimental & Molecular Medicine ; : 403-411, 2012.
Article in English | WPRIM | ID: wpr-57559

ABSTRACT

The localization of estrogen (E2) has been clearly shown in hippocampus, called local hippocampal E2. It enhanced neuronal synaptic plasticity and protected neuron form cerebral ischemia, similar to those effects of exogenous E2. However, the interactive function of hippocampal and exogenous E2 on synaptic plasticity activation and neuroprotection is still elusive. By using hippocampal H19-7 cells, we demonstrated the local hippocampal E2 that totally suppressed by aromatase inhibitor anastrozole. Anastrozole also suppressed estrogen receptor (ER)beta, but not ERalpha, expression. Specific agonist of ERalpha (PPT) and ERbeta (DPN) restored ERbeta expression in anastrozole-treated cells. In combinatorial treatment with anastrozole and phosphoinositide kinase-3 (PI-3K) signaling inhibitor wortmannin, PPT could not improve hippocampal ERbeta expression. On the other hand, DPN induced basal ERbeta translocalization into nucleus of anastrozole-treated cells. Exogenous E2 increased synaptic plasticity markers expression in H19-7 cells. However, exogenous E2 could not enhance synaptic plasticity in anastrozole-treated group. Exogenous E2 also increased cell viability and B-cell lymphoma 2 (Bcl2) expression in H2O2-treated cells. In combined treatment of anastrozole and H2O2, exogenous E2 failed to enhance cell viability and Bcl2 expression in hippocampal H19-7 cells. Our results provided the evidence of the priming role of local hippocampal E2 on exogenous E2-enhanced synaptic plasticity and viability of hippocampal neurons.


Subject(s)
Animals , Rats , Androstadienes/pharmacology , Aromatase Inhibitors/pharmacology , Cell Line , Cell Survival/drug effects , Estrogen Receptor alpha/agonists , Estrogen Receptor beta/agonists , Estrogens/metabolism , Hippocampus/cytology , Hydrogen Peroxide/pharmacology , Nervous System/drug effects , Neuronal Plasticity/drug effects , Neuroprotective Agents , Nitriles/pharmacology , Phosphatidylinositol 3-Kinase/antagonists & inhibitors , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Triazoles/pharmacology
11.
Indian J Cancer ; 2011 Oct-Dec; 48(4): 391-396
Article in English | IMSEAR | ID: sea-144516

ABSTRACT

Background: This study was undertaken to document the pattern of expression of estrogen (ER), progesterone (PR) and human epidermal growth factor receptor-2 (HER2) and the usage of HER2-targeted therapy in a large tertiary care hospital in India in the year 2008. Materials and Methods: The histopathology reports of all breast cancer patients registered in the hospital in 2008 were extracted from the electronic medical record system. All the cases were immunohistochemically evaluated for estrogen and progesterone receptor status (ER and PR), and c-erbB-2 protein (HER2) expression using standard immunoperoxidase method. The use of HER2-targeted therapies was evaluated by extracting relevant information from the database of the hospital pharmacy and case charts of patients enrolled in ongoing approved trials. Results: A total of 2001 new patients of invasive breast cancers with available pathology reports were registered in the hospital in the year 2008. ER and/or PR expression was positive in tumors of 1025 (51.2%) patients. HER2 3+ expression by immunohistochemistry (IHC) was found in 335 (16.7%) and HER2 2+ in 163 (8.1%). The triple negative phenotype was found in 596 (29.8%) patients. An estimated 441 patients were eligible to receive HER2-targeted therapy based on their HER2 status. Of these 38 (8.6%) patients received some form of HER2-targeted therapy; 20 patients (4.5%) as part of ongoing clinical trials and 18 (4.1%) as part of routine care. Conclusions: The overwhelming majority of patients eligible for HER2-targeted therapy in our institution are unable to receive it because of financial constraints and limited access to health insurance. There is a higher fraction of patients with the triple negative phenotype compared to the Western population.


Subject(s)
Adult , Aged , Breast Neoplasms/drug therapy , Breast Neoplasms/economics , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cost of Illness , Electronic Health Records , Estrogens/metabolism , Female , Health Services Accessibility , Humans , Immunohistochemistry , India , Middle Aged , Molecular Targeted Therapy , Progesterone/metabolism , Receptor, ErbB-2/metabolism , Retrospective Studies , Tertiary Care Centers , Biomarkers, Tumor/metabolism
12.
Arq. gastroenterol ; 48(3): 211-216, July-Sept. 2011. ilus, tab
Article in English | LILACS | ID: lil-599656

ABSTRACT

CONTEXT: Portal hypertension is a complication secondary to cirrhosis that is characterized by increased blood flow and/or vascular resistance in the portal system, causing the appearance of a hyperdynamic collateral circulation. Partial portal vein ligation is an experimental model used in rats to study the pathophysiological mechanisms involved in pre-hepatic portal hypertension. Estrogen E2 is an antioxidant molecule with various physiological actions. OBJECTIVES: To evaluate the antioxidant activity of endogenous estrogen in an experimental model of partial portal vein ligation by comparing intact with castrated rats. METHODS: Twenty Wistar rats, weighing on average 250 g were used and divided into four groups: sham-operated (SO); intact (I) with partial portal vein ligation (I + PPVL), castrated (C) and castrated with partial ligation of the vein (C + PPVL). Day 1: castration or sham-operation; day 7, PPVL surgery; on day 15 post-PPVL, portal pressure in the mesenteric vein of rats was measured on polygraph Letica. Lipid peroxidation in the stomach was assessed using the technique of thiobarbituric acid reactive substances and activity of antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase. Statistical analysis was done with ANOVA - Student-Newman-Keuls (mean ± SE), and P<0.05 was considered as significant. RESULTS: Portal pressure was significantly increased in C + PPVL as compared to the other groups. There was no significant difference in the group of intact rats. TBARS showed significant damage in C and C + PPVL in relation to others. Antioxidant enzymes were significantly increased in the castrated rats with subsequent PPVL as compared to the other groups. CONCLUSION: We suggest that estrogen E2 plays a protective role in intact compared with castrated rats because it presents hydrophenolic radicals in its molecule, thus acting as an antioxidant in this experimental model.


CONTEXTO: A hipertensão portal é uma complicação secundária à cirrose que tem como característica aumento do fluxo sanguíneo e/ou resistência vascular no sistema porta, causando o surgimento de uma circulação colateral hiperdinâmica. A ligadura parcial de veia porta é o modelo experimental utilizado em ratos para estudar os mecanismos fisiopatológicos envolvidos na hipertensão portal pré-hepática. O estrogênio E2 é uma molécula antioxidante com diferentes ações fisiológicas. OBJETIVOS: Verificar a ação antioxidante do estrogênio endógeno em modelo experimental de ligadura parcial de veia porta comparando ratas intactas com ratas castradas. MÉTODOS: Foram utilizadas 20 ratas Wistar, pesando em média 250 g, divididas em quatro grupos: "sham-operated" (SO); intactas com ligadura parcial da veia porta (I + LPVP); castradas (C) e castradas com ligadura parcial da veia porta (C + LPVP). No 1º dia: castração ou "sham-operated"; no 7º dia cirurgia de LPVP; no 15º dia após a LPVP, foi verificada a pressão portal na veia mesentérica das ratas, no polígrafo Letica. A lipoperoxidação no estômago foi avaliada através da técnica das substâncias reativas ao acido tiobarbitúrico e a atividade das enzimas antioxidantes superóxido dismutase, catalase e glutationa peroxidase. A análise estatística utilizada foi ANOVA - Student-Newmann-Keuls, (Média ± EP) e foi considerado significativo para P<0.05. RESULTADOS: A pressão portal mostrou aumento significativo no grupo C + LPVP em relação aos demais, não houve diferença significativa no grupo das ratas intactas. O TBARS mostrou dano estatisticamente significativo no grupo C e C + LPVP em relação aos demais. Quanto às enzimas antioxidantes, as ratas castradas e com posterior ligadura parcial de veia porta tiveram aumento significativo em relação às demais. CONCLUSÃO: Sugere-se que o estrogênio E2, por apresentar radicais hidrofenólicos em sua molécula, desempenha um papel protetor nas ratas intactas em comparação com as castradas, agindo assim, como antioxidante, neste modelo experimental.


Subject(s)
Animals , Female , Rats , Antioxidants/metabolism , Estrogens/metabolism , Hypertension, Portal/metabolism , Stomach Diseases/metabolism , Disease Models, Animal , Hypertension, Portal/pathology , Lipid Peroxidation , Ovariectomy , Rats, Wistar , Stomach Diseases/pathology , Thiobarbituric Acid Reactive Substances/metabolism
13.
IJEM-Iranian Journal of Endocrinology and Metabolism. 2011; 13 (4): 412-417
in English, Persian | IMEMR | ID: emr-137483

ABSTRACT

Very few studies have been done with regard to the gender differences of the immune system in responding to exercise, which generally do not control women's period cycle. Considering that levels of sex hormones differ during the menstrual cycle this study investigates the influence of gender differences on the response of IL-6, IL-15, cortisol and sex hormone to a single session of circuit resistance exercise in both male and female elite Handball players, while controlling CHECK on the women menstrual period cycles. The participants of the study were 12 elite Handball players, 5 men and 7 women. The circuit resistance exercise included 10 min warming, performing chest press, leg press, leg press, abdominal crunch, literal pull down, leg extension in 3 sets with 10 repetitions with 60% 1RM and 10 min cooling down. Pre, immediately and 2 hours post exercise, the blood samples were collected in order to measure IL-6, IL-15, cortisol, testosterone and estrogen levels. Results indicated that IL-6 concentration was different in the two groups after the exercise, which showed an increase in men and a decrease in women. There was no significant difference between the two groups IL-15 levels, but significant difference was observed between the two groups in cortisol, testosterone and estrogen levels. A single session of circuit resistance exercise resulted in different responses in the Immune system of men, in comparison with women


Subject(s)
Humans , Male , Female , Exercise/physiology , Interleukin-6/metabolism , Interleukin-15/metabolism , Hydrocortisone/metabolism , Testosterone/metabolism , Estrogens/metabolism , Athletes
14.
Journal of Korean Academy of Nursing ; : 191-196, 2011.
Article in Korean | WPRIM | ID: wpr-14150

ABSTRACT

PURPOSE: We investigated the effects of group III mechanoreceptors to cardiovascular responses in both pre-menopausal woman and post-menopausal woman during passive ankle dorsiflexion (PAD). METHODS: Twenty healthy volunteers (10 post-menopausal women and 10 pre-menopausal women) were recruited for this study. Stroke volume (SV), heart rate (HR), cardiac output (CO), and total vascular conductances (TVC) were measured continuously throughout the experiment. To stimulate the group III mechanoreceptors, PAD was performed for one minute. RESULTS: The results showed that mean arterial pressure (MAP) mediated by the mechanoreflex activation was significantly increased in both groups. However, this pressor response was significantly higher in post-menopausal women. This reflex significantly increased both SV and CO in pre-menopausal women, while there were no differences in post-menopausal women. There was no difference in HR in either group. The mechanoreflex significantly decreased TVC in post-menopausal woman, while there was no difference in pre-menopausal woman. CONCLUSION: The results indicate that the excessive pressor response mediated by the mechanoreflex occurs due to overactivity of group III mechanorecptors and the mechanism is produced mainly via peripheral vasoconstriction in post-menopausal women.


Subject(s)
Aged , Female , Humans , Middle Aged , Blood Pressure , Body Mass Index , Cardiac Output , Estrogens/metabolism , Heart Rate , Mechanoreceptors , Postmenopause , Premenopause , Reflex, Stretch/physiology , Stroke Volume
15.
Article in English | IMSEAR | ID: sea-139842

ABSTRACT

Aim : The aim of the present study was to investigate the level of salivary sialic acids and glycosaminoglycans with reference to salivary hormones during the normal menstrual cycle. Settings and Design: Fifty women volunteers were selected for the present study. Materials and Methods : Saliva was collected from 50 women and ovulation was detected in women with normal menstrual cycles through basal body temperature (BBT), ultrasound and salivary ferning. Samples were divided into five categories, as prepubertal (6-9 years), pre-ovulatory phase (6-12 days), ovulatory phase (13-14 days), postovulatory phase (15-26 days) and menopause (above 45 years). Each sample was subjected to evaluation of the sialic acids and glycosaminoglycans along with salivary hormones. Results : The result revealed that the ovulatory phase has increased sialic acid and glycosaminoglycans during the menstrual cycle when compared with that of the other phases. Consequently, an increased level of hormones such as luteinizing hormone and estrogen during the ovulatory period when compared to that of the pre-ovulatory and postovulatory periods appeared to be noteworthy. Statistically, analysis was performed using one way-ANOVA (LSD; post hoc method) to determine the significance as P < 0.001, 0.01, 0.05 in between the reproductive phases of the menstrual cycle. Conclusion : This study concluded that saliva-specific carbohydrates in the ovulatory saliva make the possibility to develop a biomarker for detection of ovulation by non-invasive methods.


Subject(s)
Adult , Analysis of Variance , Biomarkers/analysis , Estrogens/metabolism , Female , Glycosaminoglycans/analysis , Humans , Luteinizing Hormone/metabolism , Menstrual Cycle/metabolism , Middle Aged , Ovulation Detection/methods , Progesterone/metabolism , Saliva/chemistry , Sialic Acids/analysis
16.
Experimental & Molecular Medicine ; : 731-738, 2010.
Article in English | WPRIM | ID: wpr-158015

ABSTRACT

The nuclear receptors, steroid and xenobiotic receptor (SXR) and constitutive androstane receptor (CAR) play important functions in mediating lipid and drug metabolism in the liver. The present study demonstrates modulatory actions of estrogen in transactivations of SXR-mediated liver X receptor response element (LXRE) and CAR-mediated phenobarbital response element (PBRU). When human estrogen receptor (hERalpha) and SXR were exogenously expressed, treatment with either rifampicin or corticosterone promoted significantly the SXR-mediated transactivation of LXRE reporter gene in HepG2. However, combined treatment with estrogen plus either rifampicin or corticosterone resulted in less than 50% of the mean values of the transactivation by rifampicin or corticosterone alone. Thus, it is suggested that estrogen may repress the SXR-mediated transactivation of LXRE via functional cross-talk between ER and SXR. The CAR-mediated transactivation of PBRU was stimulated by hERalpha in the absence of estrogen. However, the potentiation by CAR agonist, TCPOBOP, was significantly repressed by moxestrol in the presence of ER. Thus, ER may play both stimulatory and inhibitory roles in modulating CAR-mediated transactivation of PBRU depending on the presence of their ligands. In summary, this study demonstrates that estrogen modulates transcriptional activity of SXR and CAR in mediating transactivation of LXRE and PBRU, respectively, of the nuclear receptor target genes through functional cross-talk between ER and the corresponding nuclear receptors.


Subject(s)
Humans , Corticosterone/pharmacology , Estrogens/metabolism , Ethinyl Estradiol/analogs & derivatives , Hep G2 Cells , Liver/metabolism , Orphan Nuclear Receptors/metabolism , Phenobarbital/metabolism , Pyridines/pharmacology , Receptor Cross-Talk , Receptors, Cytoplasmic and Nuclear/agonists , Receptors, Steroid/metabolism , Response Elements , Rifampin/pharmacology , Transcriptional Activation/drug effects
17.
Braz. j. morphol. sci ; 26(3/4): 193-197, July-Dec. 2009.
Article in English | LILACS | ID: lil-644174

ABSTRACT

Estrogens are known to influence genetic expression by interfering in cell growth and differentiation throughdifferent mechanisms, both in organs associated with reproduction and in other areas. Recently, the numberof studies investigating these receptors in different tissues by means of the immunohistochemical methodhas been increasing. Another method that has also been used recently is investigation of the expression ofRNA-m at the specific receptors by means of PCR. The effects of estrogen have been analyzed in relationto a significant number of tissue types that are not associated with reproduction, for example bones and thecardiovascular, gastrointestinal, immunological and central nervous systems. Hence, the aim of the presentstudy was to review the literature on estrogen receptors in non-target organs for the action of this hormone,i.e. in organs that are not associated with reproduction.


Subject(s)
Humans , Estrogen Receptor alpha , Estrogen Receptor beta , Estrogens , Estrogens/metabolism , Hormones , Polymerase Chain Reaction
18.
Arq. bras. endocrinol. metab ; 53(3): 310-317, Apr. 2009. ilus
Article in Portuguese | LILACS | ID: lil-517673

ABSTRACT

A deficiência de esteroides gonadais femininos acelera o ganho de massa corpórea, mas os possíveis mecanismos centrais e periféricos envolvidos no aumento da ingestão alimentar e no ganho de massa adiposa que ocorrem nessa condição são pouco conhecidos. Em modelos animais, tanto a falta quanto os defeitos na ação do estrogênio causam aumento da massa corpórea, demonstrando claramente um possível papel desse esteroide no sobrepeso pós-menopausa. Sabe-se que a obesidade e o sobrepeso estão associados a diversas comorbidades que podem levar à morte prematura. Portanto, desvendar os mecanismos relacionados ao ganho de massa corpórea é de grande relevância, assim como desenvolver estratégias que possam prevenir o seu estabelecimento. A regulação do balanço energético está associada ao controle da massa corpórea, sendo o exercício físico um importante modulador desse parâmetro homeostático. Porém, a influência do exercício físico sobre o ganho de massa corpórea durante a deficiência de estrogênio é controversa e depende do protocolo de exercício utilizado. Neste estudo, pretendemos revisar os achados que relacionam a deficiência de estrogênio ao ganho de massa corpórea em animais e seres humanos.


Female steroid hormones deficiency leads to a significant increase in body mass, but the possible central and peripheral mechanisms involved in increased food ingestion and fat accumulation in this situation are still unknown. In animal models, the specific lack of estrogen or its action produce progressive body mass gain, clearly demonstrating the possible role of this hormone in overweight after menopause. Obesity and overweight correspond to a relevant human health problem that can lead to premature death. Therefore unraveling the mechanisms underlying body mass gain is of great relevance, as well as the development of strategies to prevent its establishment. Energy balance regulation is associated with the control of body mass, and physical exercise is an important modulator of this homeostatic parameter. However, the influence of physical exercise in mass gain development during estrogen deficiency is controversial and depends on the exercise protocol used. In this study, we intend to review the data on the effects of estrogen deficiency on body mass gain in humans and animal models.


Subject(s)
Animals , Female , Humans , Mice , Rats , Energy Metabolism/physiology , Estrogens/metabolism , Exercise/physiology , Obesity/metabolism , Aromatase/metabolism , Body Fat Distribution , Body Mass Index , Estrogens/deficiency , Estrogens/genetics , Gene Deletion , Menopause/metabolism , Obesity/genetics , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism
19.
Int. j. morphol ; 26(3): 643-652, Sept. 2008. ilus, tab
Article in English | LILACS | ID: lil-556726

ABSTRACT

Increasing concern has been expressed about the declining sperm count of humans and the potential environmental effects of both synthetic and natural estrogenic endocrine disruptors (EEDs) on human reproductive health in the last few decades. However, due to paucity of knowledge, we evaluate the chronic reproductive toxicity of sesame phytoestrogenic lignans on the male Sprague Dawley (SD) rats' testis. Thirty adult male SD rats weighing 150-200g were divided into three groups. Two treated groups received a daily dose of aqueous leaves extract of Sesamum radiatum at 14.0 mg/kg bw and 28.0mg /kg bw respectively via gastric gavage, while equal volume of normal saline was administered to the control group for six weeks. Seminal analysis and hormonal assay study were analyzed using SPSS software and P< 0.05 was considered statistically significant. The results showed significant (P< 0.05) body weight gains observed in all the animals with significant (P< 0.05) weight increase in their raw testicular weights compared to control. The relative testicular weight per 100g bw was significantly (P< 0.05) higher in control than treated. However, the weight gain was dose related with a reversal in their relative testicular weight. The cauda sperm count including the motility and morphology of the treated were significantly (P< 0.05) higher than control in a dose related manner. In addition, significant (P > 0.05) increases in testosterone and a significant decrease in FSH in the high dose (treated) compared to control. Sesame phytoestrogenic lignans improves spermatozoa quality in a dose related manner.


Una mayor preocupación se ha expresado en las últimas décadas por la disminución en la cantidad de espermatozoides de los seres humanos y los posibles efectos ambientales de disruptores endocrinos estrogénicos (DES) sintéticos y naturales sobre la salud reproductiva humana. Sin embargo, debido a la escasez de conocimientos, evaluamos la toxicidad crónica para la reproducción de fitoestrógenos lignanos del sésamo en el testículo de ratas Sprague Dawley (SD) macho. Treinta ratas macho adultas, de un peso de 150-200g se dividieron en tres grupos. Dos grupos de tratamiento recibieron una dosis diaria de extracto acuoso de las hojas Sesamum radiatum de 14,0 mg/kg de peso corporal y 28,0mg / kg de peso corporal, respectivamente, a través de una sonda gástrica, mientras que igual volumen de solución salina normal se administró al grupo control durante seis semanas. El análisis seminal y estudio de ensayo hormonal fueron analizados mediante el software SPSS y P <0,05 fue considerado estadísticamente significativo. Los resultados mostraron significativas (P <0,05) ganancias de peso corporal observados en todos los animales con un peso significativo (P <0.05), aumento de peso en su peso testicular bruto en comparación con el control. El relativo peso testicular por 100 g de peso corporal fue significativamente mayor (P <0,05) en control que en tratamiento. Sin embargo, el aumento de peso dosis se ha relacionado con un retroceso en su peso relativo testicular. La cantidad de espermatozoides, incluyendo la motilidad y morfología de los que recibieron tratamiento fue significativamente más alto que el control (P <0,05) en una dosis relacionados. Además, significativo aumento en los niveles de testosterona (P> 0,05) y una disminución significativa de FSH en la dosis alta (tratados), en comparación con el control. Fitoestrógenos lignanos del sésamo mejoran la calidad de los espermatozoides en una dosis adecuada.


Subject(s)
Male , Adult , Animals , Rats , Spermatogenesis , Rats, Sprague-Dawley/anatomy & histology , Rats, Sprague-Dawley/genetics , Semen , Semen/enzymology , Sesamum/metabolism , Sesamum/chemistry , Testis/anatomy & histology , Testis , Testis/metabolism , Gas Chromatography-Mass Spectrometry/methods , Estrogens/administration & dosage , Estrogens/metabolism , Estrogens/therapeutic use , Plant Preparations/therapeutic use
20.
Rev. chil. pediatr ; 79(4): 373-380, ago. 2008. ilus
Article in Spanish | LILACS | ID: lil-517480

ABSTRACT

Background: Few information is available about uterine effects of Cadmium (Cd) exposure, where toxic agents affecting the female genital tract interact with estrogen (E) receptors, modifiying myometrial activity and the menstrual cycle, causing dysmenorrhea, infertility and spontaneous abortion. No information exists whether prenatal or early postnatal exposure may cause any gynecologic persistent adverse effect. Our finding of a second mechanism of E interaction and differences between E receptors in the various uterine cell types suggests that Cd may affect differently E interaction in each cell-type. Objective: Evaluate a possible selective effect of acute Cd exposure on E action in the uterus during prepuber age. Method: Female prepuber rats exposed to Cd 4 mg/kg and 2 hours later, treated with Estradiol-17² 0,3 mg/kg. A myometrial sample was obtained under anaesthesia 24 hours after E treatment and histologically processed for the quantification of E responses on different uterine cell-types. Results: Cd exposure potentiates E-induced uterine eosinophilia and endometrial edema and inhibits E-induced cell hypertrophy in circular myometrium and cell proliferation in luminal myometrium. Cd, in the absence of hormone stimulation, causes a slight cell hypertrophy in circular myometrium. Conclusions: Acute exposure to Cd affects differently various responses to E in the different uterine cell-types. Future studies should verify whether this effect explains Cd-induced infertility, postpubertal sex organ development and whether prenatal or early postnatal exposure to Cd induces delayed persistent effects.


Antecedentes: Existe poca información sobre efectos del cadmio (Cd) en el útero. En mujeres altera la actividad miometrial, el ciclo menstrual y causa dismenorrea, abortos espontáneos, infertilidad y mortinatos. No existe información si la exposición prenatal o postnatal temprana causa efectos ginecológicos diferidos persistentes. Los tóxicos que afectan el útero suelen interactuar con receptores de estrógeno (E). Nuestro hallazgo de un segundo mecanismo de acción de E y de diferencias entre receptores de E de los diversos tipos celulares uterinos hacen posible que el Cd interactúe con los E en forma diferente en cada tipo celular. Objetivos: Buscar un posible efecto selectivo de la exposición aguda a Cd con algunas respuestas a E en útero de rata durante la edad prepuberal. Métodos: Ratas hembra impúberes recibieron 4 mg Cd/kg p.c. y 2 h después se trataron con 0,3 mg estradiol-17(3/kg p.c; los úteros fueron obtenidos bajo anestesia a las 24 h del tratamiento con E. Los úteros se procesaron para la cuantificación de respuestas a E en cada tipo celular por separado. Resultados: La exposición a Cd incrementa la eosinofilia uterina y edema endometrial inducidos por E; inhibe las siguientes respuestas a E: hipertrofia celular en miometrio circular, proliferación celular en epitelio luminal y miometrio. En ausencia de hormona, el cadmio causa una leve hipertrofia celular en miometrio circular. Conclusiones: La exposición aguda a Cd afecta de manera diferente las respuestas a E en los diversos tipos celulares uterinos de rata prepuberal. Futuros estudios deberán verificar si este efecto explica la infertilidad causada por exposición a Cd, afecta el desarrollo postpuberal de los órganos sexuales, e investigar si la exposición prenatal o postnatal temprana induce efectos diferidos persistentes, como puede ocurrir en población infantil prenatalmente expuesta a Cd.


Subject(s)
Animals , Female , Cadmium/pharmacology , Cadmium/toxicity , Uterine Diseases/chemically induced , Receptors, Estrogen , Analysis of Variance , Edema/chemically induced , Endometrium , Endometrium/pathology , Eosinophilia/chemically induced , Estrogens/metabolism , Rats, Sprague-Dawley , Uterus , Uterus/pathology
SELECTION OF CITATIONS
SEARCH DETAIL